Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside

Overview of attention for article published in Frontiers in immunology, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 17 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 34,166 followers.

RT @FrontImmunol: New Research: Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Beds…

14 Jun 2022

Reply Repost Favourite

Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside https://t.co/xNy0wnl0HS

13 Jun 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Beds…

11 Jun 2022

Reply Repost Favourite

New Research: Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside: Glioblastoma (grade IV glioma) is the most aggressive histopathological subtype of glial tumors with inordinate… https://t.co/x6EP

11 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.